Progressive Multiple Sclerosis Clinical Trials in Barcelona
2 recruitingBarcelona, Spain
Showing 1–2 of 2 trials
Recruiting
Phase 2
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis (MS)
Progressive Multiple Sclerosis
Hoffmann-La Roche360 enrolled47 locationsNCT07282574
Recruiting
Phase 1
Obe-cel in Refractory Progressive Forms of Multiple Sclerosis
Progressive Multiple Sclerosis
Autolus Limited18 enrolled7 locationsNCT07139743